21.40
+0.60
+(2.88%)
As of 8:20:49 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 5 | 14 | 14 |
| Avg. Estimate | 4.97B | 5.11B | 20.88B | 21.36B |
| Low Estimate | 4.93B | 5.08B | 20.59B | 20.91B |
| High Estimate | 4.99B | 5.14B | 21.17B | 22.13B |
| Year Ago Sales | 4.9B | 5.09B | 20.6B | 20.88B |
| Sales Growth (year/est) | 1.44% | 0.42% | 1.34% | 2.31% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RCIB.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
| Downgrade | Barclays: Overweight to Equal-Weight | 1/21/2025 |
| Maintains | TD Securities: Buy to Buy | 9/19/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 9/19/2024 |
| Downgrade | Canaccord Genuity: Buy to Hold | 7/25/2024 |
| Maintains | Barclays: Overweight to Overweight | 4/10/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/12/2024 |